These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38696310)

  • 1. Sotatercept (Winrevair) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2024 May; 66(1702):73-75. PubMed ID: 38696310
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of pulmonary arterial hypertension in the Camerino area of central Italy and savings resulting from generic bosentan.
    Natali S; Palmieri M; Polidori C
    Eur J Hosp Pharm; 2020 Mar; 27(2):100-102. PubMed ID: 32133136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension.
    Wang S; Yu M; Zheng X; Dong S
    Drug Deliv; 2018 Nov; 25(1):1898-1909. PubMed ID: 30442035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambrisentan (Letairis) and tadalafil (Adcirca) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):2-4. PubMed ID: 26714240
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and safety of endothelin receptor antagonists combined with phosphodiesterase 5 inhibitor in the treatment of pulmonary arterial hypertension: a network meta-analysis].
    Fu WH; Chen PL; Xia JL; Fu L; Shen Y; He WJ; Chen YH; Ren N; Jiang Q; Ma R; Wang T; Wang XN; Zhang NF; Liu CL
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Feb; 45(2):158-170. PubMed ID: 35135085
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis.
    Fu W; He W; Li Y; Chen Y; Liang J; Lei H; Fu L; Chen Y; Ren N; Jiang Q; Shen Y; Ma R; Wang T; Wang X; Zhang N; Xiao D; Liu C
    Drug Deliv; 2021 Dec; 28(1):1007-1019. PubMed ID: 34060401
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
    Frost A; Janmohamed M; Fritz JS; McConnell JW; Poch D; Fortin TA; Miller CE; Chin KM; Fisher M; Eggert M; McEvoy C; Benza RL; Farber HW; Kim NH; Pfister T; Shiraga Y; McLaughlin V
    J Heart Lung Transplant; 2019 Jan; 38(1):43-50. PubMed ID: 30391194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
    LeVarge BL; Channick RN
    Expert Rev Respir Med; 2012 Jun; 6(3):255-65. PubMed ID: 22788940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension.
    Wu S; Hoang HB; Yang JZ; Papamatheakis DG; Poch DS; Alotaibi M; Lombardi S; Rodriguez C; Kim NH; Fernandes TM
    Chest; 2022 Dec; 162(6):1360-1372. PubMed ID: 35841932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
    Hoeper MM; Badesch DB; Ghofrani HA; Gibbs JSR; Gomberg-Maitland M; McLaughlin VV; Preston IR; Souza R; Waxman AB; Grünig E; Kopeć G; Meyer G; Olsson KM; Rosenkranz S; Xu Y; Miller B; Fowler M; Butler J; Koglin J; de Oliveira Pena J; Humbert M;
    N Engl J Med; 2023 Apr; 388(16):1478-1490. PubMed ID: 36877098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension.
    Momoi M; Hiraide T; Shinya Y; Momota H; Fukui S; Kawakami M; Itabashi Y; Fukuda K; Kataoka M
    Ther Adv Respir Dis; 2021; 15():1753466621995048. PubMed ID: 33627044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprocitentan (Tryvio) for hypertension.
    Med Lett Drugs Ther; 2024 Jun; 66(1704):92-93. PubMed ID: 38905532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia].
    Shmalts AA; Gorbachevsky SV
    Ter Arkh; 2020 Dec; 92(12):80-85. PubMed ID: 33720578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension.
    Waxman AB; Systrom DM; Manimaran S; de Oliveira Pena J; Lu J; Rischard FP
    Circ Heart Fail; 2024 May; 17(5):e011227. PubMed ID: 38572639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of switch from bosentan to macitentan in children and young adults with pulmonary arterial hypertension: extended study results.
    Aypar E; Alehan D; Karagöz T; Aykan H; Ertugrul İ
    Cardiol Young; 2020 May; 30(5):681-685. PubMed ID: 32290885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri
    Degering J; Egenlauf B; Harutyunova S; Benjamin N; Salkić A; Xanthouli P; Eichstaedt CA; Seeger R; Sitbon O; Grünig E
    Respir Res; 2023 Jan; 24(1):18. PubMed ID: 36653855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy With Inhaled Treprostinil, Macitentan, and Tadalafil/Riociguat in High-Risk Pulmonary Arterial Hypertension.
    El-Kersh K
    Am J Ther; 2023 Sep-Oct 01; 30(5):e499-e502. PubMed ID: 37713711
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative bioavailability of inhaled treprostinil administered as LIQ861 and Tyvaso® in healthy subjects.
    Roscigno RF; Vaughn T; Parsley E; Hunt T; Eldon MA; Rubin LJ
    Vascul Pharmacol; 2021 Jun; 138():106840. PubMed ID: 33545364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treprostinil for the treatment of pulmonary arterial hypertension.
    de Lartigue J
    Drugs Today (Barc); 2014 Aug; 50(8):557-65. PubMed ID: 25187906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration.
    Kumar P; Thudium E; Laliberte K; Zaccardelli D; Nelsen A
    Clin Pharmacokinet; 2016 Dec; 55(12):1495-1505. PubMed ID: 27286723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.